webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Fmoc-N-amido-PEG1-acetic acid

  CAS No.: 260367-12-2   Cat No.: BADC-01112   Purity: ≥95% 4.5  

Fmoc-N-amido-PEG1-acetic acid is a PEGylated linker intermediate featuring an Fmoc-protected amide, enabling peptide elongation or payload attachment in ADC systems. Its hydrophilic PEG spacer improves solubility and flexibility, facilitating efficient antibody-drug conjugate construction.

Fmoc-N-amido-PEG1-acetic acid

Structure of 260367-12-2

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C19H19NO5
Molecular Weight
341.36
Shipping
Room temperature
Shipping
Store at -20°C, keep in dry and avoid sunlight

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Fmoc-NH-PEG1-CH2COOH; Fmoc-O1Pen-OH; 5- (Fmoc- amino) - 3- oxapentanoic Acid; 5-(9-Fluorenylmethyloxycarbonyl-amino)-3-oxapentanoic acid; Acetic acid, 2-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethoxy]-; Fmoc-AEA-OH; 2-[2-(Fmoc-amino)ethoxy]acetic Acid
IUPAC Name
2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethoxy]acetic acid
Canonical SMILES
C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCOCC(=O)O
InChI
InChI=1S/C19H19NO5/c21-18(22)12-24-10-9-20-19(23)25-11-17-15-7-3-1-5-13(15)14-6-2-4-8-16(14)17/h1-8,17H,9-12H2,(H,20,23)(H,21,22)
InChIKey
LBVXPUINIMIGAU-UHFFFAOYSA-N
Density
1.287±0.06 g/cm3 (Predicted)
Solubility
Soluble in DMSO (10 mm)
Melting Point
83-89°C
Flash Point
294.8±30.1 °C
Index Of Refraction
1.630
PSA
84.86000
Vapor Pressure
0.0±1.6 mmHg at 25°C
Appearance
Pale Yellow or Colorless Oily Matter
Shipping
Room temperature
Storage
Store at -20°C, keep in dry and avoid sunlight
Boiling Point
602.6±40.0°C (Predicted)
Form
Solid
Biological Activity
Fmoc-NH-PEG1-CH2COOH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1] . In Vitro: ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker

Fmoc-N-amido-PEG1-acetic acid, a versatile chemical linker, finds wide utilization in biochemical and pharmaceutical research. Below are four key applications of this compound:

Peptide Synthesis: Integral to solid-phase peptide synthesis, Fmoc-N-amido-PEG1-acetic acid plays a crucial role in constructing peptides. The Fmoc group shields the terminal amino group throughout the synthesis process, enabling the sequential addition of amino acids. This method offers researchers a dependable approach to creating intricate peptides with elevated yields and purity levels.

Drug Delivery: This compound serves as a cornerstone in designing drug delivery systems that leverage PEG to enhance drug solubility, stability, and biocompatibility. By conjugating drugs to Fmoc-N-amido-PEG1-acetic acid, researchers can enhance the pharmacokinetic properties of the resulting compounds. This augmentation not only boosts therapeutic efficacy but also mitigates the adverse effects associated with drug treatments.

Surface Modification: Employing Fmoc-N-amido-PEG1-acetic acid enhances the biocompatibility and functionality of nanoparticle surfaces, biomaterials, and medical devices. The PEG component forms a hydrophilic layer that reduces protein adsorption and cellular interactions, crucial for applications spanning biosensors to implantable devices. This modification guarantees the stability and optimal performance of these devices within biological settings.

Protein Engineering: In the realm of protein engineering, Fmoc-N-amido-PEG1-acetic acid enables site-specific PEGylation of proteins, enhancing their pharmacokinetic characteristics. By attaching PEG chains to precise residues, researchers can prolong the circulation time of therapeutic proteins in the bloodstream while lowering their immunogenicity. This transformation renders the proteins more suitable for diverse therapeutic applications, promising advancements in the realm of medical treatments.

1. The Stephan Curve revisited
William H Bowen Odontology. 2013 Jan;101(1):2-8. doi: 10.1007/s10266-012-0092-z. Epub 2012 Dec 6.
The Stephan Curve has played a dominant role in caries research over the past several decades. What is so remarkable about the Stephan Curve is the plethora of interactions it illustrates and yet acid production remains the dominant focus. Using sophisticated technology, it is possible to measure pH changes in plaque; however, these observations may carry a false sense of accuracy. Recent observations have shown that there may be multiple pH values within the plaque matrix, thus emphasizing the importance of the milieu within which acid is formed. Although acid production is indeed the immediate proximate cause of tooth dissolution, the influence of alkali production within plaque has received relative scant attention. Excessive reliance on Stephan Curve leads to describing foods as "safe" if they do not lower the pH below the so-called "critical pH" at which point it is postulated enamel dissolves. Acid production is just one of many biological processes that occur within plaque when exposed to sugar. Exploration of methods to enhance alkali production could produce rich research dividends.
2. Atroposelective Synthesis of 1,1'-Bipyrroles Bearing a Chiral N-N Axis: Chiral Phosphoric Acid Catalysis with Lewis Acid Induced Enantiodivergence
Yaru Gao, Luo-Yu Wang, Tao Zhang, Bin-Miao Yang, Yu Zhao Angew Chem Int Ed Engl. 2022 Apr 11;61(16):e202200371. doi: 10.1002/anie.202200371. Epub 2022 Feb 24.
We present herein a highly efficient atroposelective synthesis of axially chiral 1,1'-bipyrroles bearing an N-N linkage from simple hydrazine and 1,4-diones. Further product derivatizations led to axially chiral bifunctional compounds with high potential in asymmetric catalysis. For this chrial phosphoric acid (CPA)-catalyzed double Paal-Knorr reaction, an intriguing Fe(OTf)3 -induced enantiodivergence was also observed.
3. Acidity characterization of heterogeneous catalysts by solid-state NMR spectroscopy using probe molecules
Anmin Zheng, Shang-Bin Liu, Feng Deng Solid State Nucl Magn Reson. 2013 Oct-Nov;55-56:12-27. doi: 10.1016/j.ssnmr.2013.09.001. Epub 2013 Sep 20.
Characterization of the surface acidic properties of solid acid catalysts is a key issue in heterogeneous catalysis. Important acid features of solid acids, such as their type (Brønsted vs. Lewis acid), distribution and accessibility (internal vs. external sites), concentration (amount), and strength of acid sites are crucial factors dictating their reactivity and selectivity. This short review provides information on different solid-state NMR techniques used for acidity characterization of solid acid catalysts. In particular, different approaches using probe molecules containing a specific nucleus of interest, such as pyridine-d5, 2-(13)C-acetone, trimethylphosphine, and trimethylphosphine oxide, are compared. Incorporation of valuable information (such as the adsorption structure, deprotonation energy, and NMR parameters) from density functional theory (DFT) calculations can yield explicit correlations between the chemical shift of adsorbed probe molecules and the intrinsic acid strength of solid acids. Methods that combine experimental NMR data with DFT calculations can therefore provide both qualitative and quantitative information on acid sites.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Py-MPB-amino-C3-PBD | MAC glucuronide linker-2 | Pyrrolobenzodiazepine (PBD) | Mal-PEG4-VA-PBD | VA-PAB-PBD | MC-VC-PAB-Tubulysin M | N-SMP | Ald-PEG23-SPDP | Azide-C2-SS-C2-biotin | DBCO-acid | Fmoc-N-amido-PEG1-acetic acid
Send Inquiry
Verification code
Inquiry Basket